Quantedge Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-33,700
Closed -$1.85M 209
2022
Q2
$1.85M Buy
33,700
+26,200
+349% +$1.52M 0.37% 86
2022
Q1
$566K Buy
+7,500
New +$512K 0.17% 126

Other funds holding ACLS

Quantedge Capital's ACLS Position: Q3 2022 in Review

Quantedge Capital sold out of Axcelis (ACLS) in Q3 2022, closing a stake of 33,700 shares — an estimated $1.85M sold.

Quantedge Capital first reported a position in ACLS in Q1 2022 and held it in 2 quarters. The position peaked at $1.85M in Q2 2022. 287 funds tracked by Wall St. Rank hold ACLS as of Q3 2022.

  • Quantedge Capital reported no remaining Axcelis position as of Q3 2022 after selling out during the quarter.
  • Quantedge Capital sold 33,700 Axcelis shares in Q3 2022, an estimated $1.85M.
  • Quantedge Capital first reported a position in Axcelis in Q1 2022 and held it in 2 quarters.
  • Quantedge Capital's Axcelis position peaked at $1.85M in Q2 2022.
  • 287 funds tracked by Wall St. Rank held Axcelis as of Q3 2022.

Based on Quantedge Capital's 13F filing for Q3 2022, filed 10 Nov 2022.